Bruush Oral Care Inc. BRSHF
0.00
0.00
NaN
as of 25 Sep
- Market cap
- $8.7M
- P/E
- 0.0×
Follow BRSHF
Growth Flags
show if company had growth for consecutive years
| Older periods | Dec '22 | Jan '23 | Mar '23 | Apr '23 | |
|---|---|---|---|---|---|
P/E ratio |
+6 more quarters Free account |
— | — | 0.00 | 0.00 |
P/S ratio |
— | — | 1.23 | 1.68 | |
P/FCF ratio |
— | — | 0.00 | 0.00 | |
P/Operating CF |
— | — | (0.45) | (0.62) | |
P/B ratio |
— | — | 0.00 | 0.00 | |
Price to Tangible BV |
— | — | 0.00 | 0.00 | |
EV/Sales |
— | — | 2.48 | 2.91 | |
EV/EBITDA |
— | — | 0.00 | 0.00 | |
EV/Operating CF |
— | — | (3.07) | (0.53) | |
EV/FCF |
— | — | (3.08) | (0.53) | |
Quick Ratio |
0.10 | 0.10 | 0.06 | 0.06 | |
Current Ratio |
0.46 | 0.46 | 0.15 | 0.15 | |
Net Debt/EBITDA |
0.00 | 0.00 | (1.35) | (1.35) | |
Debt/Assets |
0.00% | 0.00% | 262.18% | 262.26% | |
Debt/Equity |
0.00 | 0.00 | (0.45) | (0.45) | |
Asset Turnover |
0.00 | 0.00 | 1.65 | 1.67 | |
Operating CF/Net income |
0.00 | 0.00 | 9.99 | 9.99 | |
Capex/Depreciation |
0.00 | 0.00 | (0.67) | (0.67) | |
Interest Coverage |
— | — | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.46% | 0.46% | |
Selling, General and Administrative Expense of Revenue |
— | — | 562.58% | 398.92% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
— | — | 0.00% | 124.79% | |
Graham Net Nets |
— | — | (2.44) | (1.77) | |
Graham Number |
— | — | 0.00 | 81.65 | |
Earnings Yield |
— | — | (485.60%) | (485.60%) | |
Free Cash Flow Yield |
— | — | (65.38%) | (323.81%) | |
Revenue per Share |
— | — | 0.00 | 0.65 | |
Operating CF per Share |
0.00 | 0.00 | 0.00 | (9.52) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 | (9.52) | |
Cash per Share |
0.00 | 0.00 | 0.00 | 0.39 | |
Shareholders Equity per Share |
0.00 | 0.00 | 0.00 | (10.38) | |
Interest Debt per Share |
— | — | 0.00 | 0.00 | |
Book value per Share |
0.00 | 0.00 | 0.00 | (10.38) | |
Free Cash Flow |
0.00 | 0.00 | (4.75) | (4.75) | |
Working Capital |
(1.41) | (1.41) | (5.18) | (5.18) | |
Capital Expenditures |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Current Asset Value |
(1.41) | (1.41) | (5.18) | (5.18) | |
EV/EBIT |
— | — | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
— | — | (145.71%) | (145.96%) | |
Price to Operating Income |
— | — | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
— | 0.14 | 0.16 | 0.16 | |
Average Payables |
— | 1.90 | 1.83 | 1.83 | |
Average Inventory |
— | 0.30 | 0.19 | 0.19 | |
Average Assets |
0.60 | 0.60 | 1.04 | 1.04 | |
Average Common Equity |
— | (5.06) | (3.29) | (3.29) |
Columns are period end dates